Neurogene (NGNE) Net Margin: 2019-2025
Historic Net Margin for Neurogene (NGNE) over the last 3 years, with Sep 2025 value amounting to 50,240.48%.
- Neurogene's Net Margin fell 5690163.00% to 50,240.48% in Q3 2025 from the same period last year, while for Sep 2025 it was 14,225.74%, marking a year-over-year increase of 824632.00%. This contributed to the annual value of -8,184.43% for FY2024, which is 19625586.00% down from last year.
- According to the latest figures from Q3 2025, Neurogene's Net Margin is 50,240.48%, which was up 60.06% from 31,387.84% recorded in Q2 2025.
- Neurogene's Net Margin's 5-year high stood at 408,700.00% during Q1 2023, with a 5-year trough of 2,834.05% in Q1 2024.
- Its 3-year average for Net Margin is 125,450.89%, with a median of 50,240.48% in 2025.
- In the last 5 years, Neurogene's Net Margin slumped by 40,586,595bps in 2024 and then skyrocketed by 2,789,215bps in 2025.
- Quarterly analysis of 3 years shows Neurogene's Net Margin stood at 82,170.59% in 2023, then tumbled by 7,742,276bps to 4,747.83% in 2024, then plummeted by 5,690,163bps to 50,240.48% in 2025.
- Its last three reported values are 50,240.48% in Q3 2025, 31,387.84% for Q2 2025, and 28,491.25% during Q1 2025.